the direct medical costs of breast cancer in iran: analyzing the patient′s level data from a cancer specific hospital in isfahan
Clicks: 169
ID: 192679
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
169 views
17 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #73 of 223 articles by views in italian journal of animal science
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 223 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background: Breast cancer is one of the main causes of mortality and morbidity world-wide. The estimation of the direct medical costs of breast cancer can help payers of the cost to understand the burden of breast cancer on their limited financial resources as well as the society.
Methods: We used a cross-sectional study to calculate the direct medical costs of breast cancer among women in Isfahan, Iran. The medical records of all patients which were registered in Seyed Al-Shohada Hospital between March 2005 and March 2010 were reviewed. The relevant data from patients′ profiles extracted. The direct medical costs of received services were calculated with both public and private tariffs.
Results: The total numbers of 467 patients in various disease stages were included into the study. The average age of patients was 49 years.
The average direct cost per patient per month in stages I to IV were 222.17, 224.61, 316.51 and 828.52 US$, respectively. The surgery cost was the main cost driver for stages I and II with private tariffs. However for stages III and IV, the medication cost was the main cost component for managing breast cancer .
Conclusions: The direct economic cost of breast cancer in Iran is very high; nonetheless, as the age of breast cancer in Iran is nearly 10 years lower than Western countries, the burden of the disease in Iran is expected to be significantly high. Medication therapy is the main cost component of the breast cancer.
| Reference Key |
davari2013internationalthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Majid Davari;Farkhondeh Yazdanpanah;Abolfazl Aslani;Mohsen Hosseini;Ali Reza Nazari;Fairborz Mokarian |
| Journal | italian journal of animal science |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.